Literature DB >> 14741143

Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation.

S Michael Marcy1, Katrin S Kohl, Ron Dagan, David Nalin, Michael Blum, Marcy Connell Jones, John Hansen, Jerry Labadie, Lucia Lee, Bryan L Martin, Katherine O'Brien, Edward Rothstein, Patricia Vermeer.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 14741143     DOI： 10.1016/j.vaccine.2003.09.007

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  35 in total

1.  Fever following immunization with influenza A (H1N1) vaccine in children: a survey-based study in the Netherlands.

Authors:  Nancy Broos; Eugène P van Puijenbroek; Kees van Grootheest
Journal:  Drug Saf       Date:  2010-12-01       Impact factor: 5.606

2.  Innovative Digital Tools and Surveillance Systems for the Timely Detection of Adverse Events at the Point of Care: A Proof-of-Concept Study.

Authors:  Christian Hoppe; Patrick Obermeier; Susann Muehlhans; Maren Alchikh; Lea Seeber; Franziska Tief; Katharina Karsch; Xi Chen; Sindy Boettcher; Sabine Diedrich; Tim Conrad; Bron Kisler; Barbara Rath
Journal:  Drug Saf       Date:  2016-10       Impact factor: 5.606

3.  Comparison of the tolerability of newly introduced childhood vaccines in the Netherlands.

Authors:  Jeanet M Kemmeren; Nicoline At van der Maas; Hester E de Melker
Journal:  Eur J Pediatr       Date:  2017-04-20       Impact factor: 3.183

4.  Active assessment of adverse events following yellow fever vaccination of persons aged 60 years and more.

Authors:  Karina Takesaki Miyaji; André Machado Luiz; Amanda Nazareth Lara; Tania do Socorro Souza Chaves; Roberta de Oliveira Piorelli; Marta Heloisa Lopes; Ana Marli Christovam Sartori
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

5.  Awareness and utilization of reporting pathways for adverse events following immunization: online survey among pediatricians in Russia and Germany.

Authors:  Susann Muehlhans; Max von Kleist; Tatiana Gretchukha; Martin Terhardt; Ulrich Fegeler; Wolfgang Maurer; Leila Namazova-Baranova; Gerhard Gaedicke; Alexander Baranov; Barbara Rath
Journal:  Paediatr Drugs       Date:  2014-08       Impact factor: 3.022

6.  A randomized, open-label clinical trial to evaluate immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Easyfour®-TT) with Quadrovax® in Indian infants.

Authors:  Lalitendu Mohanty; Sunil Sharma; Beauty Behera; Sachin Panwar; Charu Paliwal; Anit Singh; Anu Gupta; Deepak Chandra Chilkoti
Journal:  Hum Vaccin Immunother       Date:  2017-07-12       Impact factor: 3.452

7.  LncRNA MALAT1 promotes relapse of breast cancer patients with postoperative fever.

Authors:  Zhihua Li; Liang Xu; Yong Liu; Shaokun Fu; Jianhong Tu; Yangyang Hu; Qiuyun Xiong
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

8.  The early-onset febrile reaction following vaccination and associated factors: An exploratory sub-study based on the Ebola vaccine clinical trial.

Authors:  Qigang Dai; Qi Liang; Yuemei Hu; Fanyue Meng; Jingxin Li; Lihua Hou; Hailong Zhou; Kai Chu; Xiaokui Hu; Rong Tang; Wenjuan Wang; Jialei Hu; Haodi Huang; Zhen Li; Shuqi Yang; Fengcai Zhu
Journal:  Hum Vaccin Immunother       Date:  2017-02-22       Impact factor: 3.452

9.  Hypotonic-hyporesponsive episodes after administration of hexavalent DTP-based combination vaccine: A description of 12 cases.

Authors:  Alessandro Vigo; Giulia Costagliola; Elisa Ferrero; Silvia Noce
Journal:  Hum Vaccin Immunother       Date:  2017-02-21       Impact factor: 3.452

10.  Template protocol for clinical trials investigating vaccines--focus on safety elements.

Authors:  Jan Bonhoeffer; Egeruan B Imoukhuede; Grace Aldrovandi; Novilia S Bachtiar; Eng-Soon Chan; Soju Chang; Robert T Chen; Rohini Fernandopulle; Karen L Goldenthal; James D Heffelfinger; Shah Hossain; Indira Jevaji; Ali Khamesipour; Sonali Kochhar; Mamodikoe Makhene; Elissa Malkin; David Nalin; Rebecca Prevots; Ranjan Ramasamy; Sarah Sellers; Johan Vekemans; Kenneth B Walker; Pam Wilson; Virginia Wong; Khalequz Zaman; Ulrich Heininger
Journal:  Vaccine       Date:  2013-03-13       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.